What is Novanta's revenue?
Novanta's annual corporate revenue streams reflect strong commercial demand for its three primary operating business segments: Medical Solutions, Precision Motion, and Vision Technologies. Consistently achieving strong financial results, the company reports yearly revenues approaching or exceeding the milestone of nearly one billion dollars. This consistent revenue generation is supported by long-term customer partnerships with leading global medical equipment manufacturers and advanced industrial automation providers who rely on its precision subsystems.
Related FAQs
Novanta Inc. manufactures precision photonics, vision, and precise motion control components utilized in advanced medical and industrial original equipment manufacturing applications.
Nucor Corporation is the largest steel producer in the United States and North America's foremost sustainable steel recycling and manufacturing enterprise, utilizing advanced electric arc furnaces to produce steel products.
Novanta Inc.
Novanta maintains a high price-to-earnings ratio that reflects strong investor confidence, premium market valuation multiples, and expectations for robust future earnings growth within the specialized medical and technology manufacturing sectors.
Novanta Inc.
NOVT represents the stock ticker symbol for Novanta Inc., an innovative multinational technology enterprise focused on mission-critical subsystems and components for medical and advanced industrial original equipment manufacturers.
NOVT is the official stock ticker symbol for Novanta Inc., a prominent global technology enterprise publicly traded on the Nasdaq stock exchange.
Analysts tracking specialized corporate entities or technology firms trading under tickers like Novt maintain a focused evaluation on operational milestone execution, financial liquidity, and sector demand trends.
Novanta is widely regarded as an exceptional, high-quality technology enterprise specializing in proprietary trusted photonics, precision motion, and vision technologies for medical and advanced industrial original equipment manufacturers.
For the most recent dividend cycle in 2026, Nutrien (NTR) declared a dividend of $0.55 per share. The company traded ex-dividend on June 30, 2026, meaning that shareholders of record as of that date were entitled to receive the payment.
Wall Street analyst consensus for Novanta (ticker NOVT) leans heavily toward a buy recommendation, driven by its strong positioning in advanced photonics, precision motion, and medical technology equipment.
Novanta Inc. (NASDAQ: NOVT) trades at a market price of approximately $142.55 per share.
Equity research analysts covering Novanta Inc., which trades on the Nasdaq stock exchange under the ticker symbol NOVT, maintain a generally positive long-term consensus outlook.
Novanta Inc.
Novanta Inc. is a fully established, publicly traded corporate entity listed on the NASDAQ global select market under a designated ticker symbol.
Novanta Inc.
Novanta Inc., traded under the ticker symbol NOVT, belongs to the Electronic Technology sector.
Novanta fosters a high-performance corporate culture centered on innovation, collaboration, integrity, and continuous technological problem-solving.